医学
达拉图穆马
来那度胺
地塞米松
多发性骨髓瘤
内科学
硼替佐米
肿瘤科
作者
Pieter Sonneveld,Meletios Α. Dimopoulos,Mario Boccadoro,Hang Quach,P. Joy Ho,Meral Beksaç,Cyrille Hulin,Elisabetta Antonioli,Xavier Leleu,Silvia Mangiacavalli,Aurore Perrot,Michèle Cavo,Angelo Belotti,Annemiek Broijl,Francesca Gay,Roberto Mina,Inger S. Nijhof,Niels W.C.J. van de Donk,Eirini Katodritou,Fredrik Schjesvold
标识
DOI：10.1056/nejmoa2312054
摘要
The addition of subcutaneous daratumumab to VRd induction and consolidation therapy and to lenalidomide maintenance therapy conferred a significant benefit with respect to progression-free survival among transplantation-eligible patients with newly diagnosed multiple myeloma. (Funded by the European Myeloma Network in collaboration with Janssen Research and Development; PERSEUS ClinicalTrials.gov number, NCT03710603; EudraCT number, 2018-002992-16.).
科研通智能强力驱动
Strongly Powered by AbleSci AI
PDF的下载单位、IP信息已删除
(2025-6-4)
Maestro_S
null
Criminology34
嘻嘻哈哈
369ninja
v0id
学霸业
吃葡萄不吐葡萄皮
奔跑
极限001
GingerF
pluto
无极微光
忧心的曼凝
秋风
胡润泽
sunnymoon
Nole
风吹麦浪
sissiarno
皖公网安备34019202002308
